Cargando…
Knowledge-based mechanistic modeling accurately predicts disease progression with gefitinib in EGFR-mutant lung adenocarcinoma
Lung adenocarcinoma (LUAD) is associated with a low survival rate at advanced stages. Although the development of targeted therapies has improved outcomes in LUAD patients with identified and specific genetic alterations, such as activating mutations on the epidermal growth factor receptor gene (EGF...
Autores principales: | L’Hostis, Adèle, Palgen, Jean-Louis, Perrillat-Mercerot, Angélique, Peyronnet, Emmanuel, Jacob, Evgueni, Bosley, James, Duruisseaux, Michaël, Toueg, Raphaël, Lefèvre, Lucile, Kahoul, Riad, Ceres, Nicoletta, Monteiro, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390488/ https://www.ncbi.nlm.nih.gov/pubmed/37524705 http://dx.doi.org/10.1038/s41540-023-00292-7 |
Ejemplares similares
-
Empirical methods for the validation of time-to-event mathematical models taking into account uncertainty and variability: application to EGFR + lung adenocarcinoma
por: Jacob, Evgueni, et al.
Publicado: (2023) -
Integration of Heterogeneous Biological Data in Multiscale Mechanistic Model Calibration: Application to Lung Adenocarcinoma
por: Palgen, Jean-Louis, et al.
Publicado: (2022) -
Performance assessment of concrete structures and engineered barriers for nuclear applications: conclusions of RILEM TC 226-CNM
por: L'Hostis, Valérie, et al.
Publicado: (2016) -
An Auto-Focusing Method in a Microscopic Testbed for Optical Discs
por: Tang, Xiao, et al.
Publicado: (2000) -
The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery
por: Scotet, Virginie, et al.
Publicado: (2020)